about
Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung InjuryIndoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice.p-Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stressPotential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism.Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM.Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery.Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.Stability of benzylpenicillin potassium and ampicillin in an elastomeric infusion pump.Pharmacokinetic and pharmacodynamic studies of pregabalin suppositories based on pharmacological researchOral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials
P50
Q35666900-BB588D12-D73B-45E1-90B3-8184506379F6Q39466056-20F358B7-7339-4B02-B7D7-BA3AD937A0A5Q41653544-3CF7E782-887C-4E63-BA8A-FBBDD4DF8721Q41769243-690EEF0F-7762-4435-855B-DE9A34FD4343Q47111743-32F1DECB-C70B-4822-88B3-52368E74C6C7Q47259673-A35395A8-9880-4D97-9D8F-6149A99549D0Q50476676-E94178F4-BFC6-45D3-A98E-0DF95A669C96Q51004841-CBD1CE21-76B4-4730-8B5C-FA3417222847Q52358669-D66E58C4-1D53-4698-9EE5-3931347213B5Q52567489-6D3B7A0B-0874-4007-B35F-49570077B460Q54226078-89F4EB5A-878E-4E06-8769-E6CFF725E459Q90265926-25DBD491-7961-4641-8B6E-4D09B66FAEB4Q91252788-31A4E010-3E77-4B3F-AD7B-CF7D86734AC5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yuki Enoki
@en
Yuki Enoki
@nl
type
label
Yuki Enoki
@en
Yuki Enoki
@nl
prefLabel
Yuki Enoki
@en
Yuki Enoki
@nl
P31
P496
0000-0002-5934-0670